Recombinant human tumor necrosis factor (r-TNF) inhibits growth of various mouse tumor cell lines both in vitro and in vivo. Treatment of established tumor nodules with intratumoral (i.t.) injection of r-TNF caused hemorrhagic necrosis of tumor and temporary disappearance of tumor mass. However, a s
Antitumor effects of the combination immunotherapy with interleukin-12 and tumor necrosis factor α in mice
✍ Scribed by W. Lasek; Wojciech Feleszko; Jakub Goląb; Tomasz Stokłosa; Maria Marczak; Anna Dąbrowska; Magdalena Malejczyk; Marek Jakóbisiak
- Publisher
- Springer-Verlag
- Year
- 1997
- Tongue
- English
- Weight
- 435 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Liposomes as drug carriers in cancer chemotherapy have attracted considerable interest. To enhance the therapeutic effect of Adriamycin entrapped in liposomes (Lip-ADM) on human solid tumors, we investigated the therapeutic effects of Lip-ADM in combination with recombinant human tumor necrosis fact
The anti-tumor activity of partially purified tumor necrosis factor (TNF) was analysed in combination with chemotherapeutic drugs against intradermally transplanted Meth A sarcoma. Tumors were allowed to grow until they reached an average diameter of about 8 mm. TNF was given once i.v. (16,000 units